B.Riley/FBR Reiterates Buy Rating on CytoSorbents (CTSO) Following NDR
Tweet Send to a Friend
B.Riley/FBR analyst Andrew D'Silva reiterated a Buy rating and $16.00 price target on CytoSorbents (NASDAQ: CTSO) following a virtual NDR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
